Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 06-2005 | 06-2004 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | 2,550 | 3,050 | 4,960 |
| Depreciation Amortization | N/A | N/A | 1,660 | 1,810 | 1,600 |
| Other Working Capital | N/A | N/A | -5,770 | -5,760 | 0 |
| Other Operating Activity | 0 | 0 | 530 | -1,100 | -1,490 |
| Operating Cash Flow | $N/A | $N/A | $-1,030 | $-2,000 | $5,070 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -2,430 | -1,600 | -810 |
| Net Acquisitions | N/A | N/A | -3,300 | -3,420 | -3,150 |
| Other Investing Activity | 0 | 0 | 0 | 100 | -10 |
| Investing Cash Flow | $N/A | $N/A | $-5,730 | $-4,920 | $-3,970 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 7,750 | 5,020 | 2,160 |
| Financing Cash Flow | $N/A | $N/A | $7,750 | $5,020 | $2,160 |
| Exchange Rate Effect | N/A | N/A | -1,130 | 40 | -290 |
| Beginning Cash Position | N/A | N/A | 3,190 | 5,050 | 2,080 |
| End Cash Position | N/A | N/A | 3,040 | 3,190 | 5,050 |
| Net Cash Flow | $N/A | $N/A | $-150 | $-1,850 | $2,970 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | -1,030 | -2,000 | 5,070 |
| Free Cash Flow | 0 | 0 | -1,030 | -2,000 | 5,070 |